Target intelligence / Profile preview

Neisseria meningitidis serogroup Y polysaccharide (None)

Target
None
Molecular classification
Capsular Polysaccharide, Antigen
01

Overview

The Neisseria meningitidis serogroup Y polysaccharide is a capsular polysaccharide that serves as the primary antigenic determinant for classifying N. meningitidis into serogroup Y. The capsule is a major virulence factor, enabling the bacterium to evade host immune responses and cause invasive diseases such as meningitis and septicemia. It consists of repeating disaccharide units of D-glucose and N-acetylneuraminic acid linked via α(2→6) and α(1→4) glycosidic bonds. Antibodies targeting this capsule confer protection against infection, making it a key component of quadrivalent conjugate vaccines (MenACWY).

02

Mechanism of action

Antibody-mediated neutralization and opsonization

03

Biological functions

Capsule formationImmune evasionProtection against complement-mediated killingBacterial virulence
04

Disease associations

MeningitisSepticemiaInvasive Meningococcal Disease
05

Interacting drugs

MenACWY vaccines

1 more in the full profile.

Beyond the preview

Go deeper on Neisseria meningitidis serogroup Y polysaccharide (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neisseria meningitidis serogroup Y polysaccharide (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call